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Introduction: Lymph node yield (LNY) in neck dissection has been identified as a prognostic factor in oral
cavity cancer. The purpose of this study was to investigate the impact of additional use of optical imaging
on LNY in therapeutic ND in oral cancer.
Methods: Consecutive patients with oral squamous cell carcinoma with clinical neck metastasis planned
for primary tumor resection were randomized to conventional neck dissection or near-infrared fluo-
rescence (NIRF)-guided neck dissection, respectively. In the intervention group, patients were injected
with ICG-Nanocoll prior to surgery. Intraoperatively, an optical hand-held camera system was used for
lymph node identification. Also, NIRF imaging of the neck specimen was performed, and optical signals
were pinned with needle markings to guide the pathological examination. The endpoint of the study was
LNY per neck side in levels Ib-III.
Results: 31 patients were included with 18 neck sides in the control group and 18 neck sides in the
intervention group for evaluation. During NIRF-guided ND, individual lymph nodes could be identified by
a bright fluorescent signal and individual tumor-related drainage patterns could be observed in the neck.
The LNY in the intervention group was significantly higher compared to the control group (p¼ 0.032)
with a mean of 24 LN (range: 12e33 LN in levels Ib-III compared to 18 LN (range: 10e36 LN) in the
control group, respectively.
Conclusions: NIRF-guided ND significantly improved the nodal yield compared to the control group.
Intraoperative real-time optical imaging enabled direct visualization of tumor-related drainage patterns
within the neck lymphatics.
© 2019 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Neck dissection (ND) is an integrated standard surgical pro-
cedure in head and neck cancer both for diagnostic and therapeuticology, Head & Neck Surgery
en, Blegdamsvej 9, DK-2100,
.dk (A. Christensen), karina.
(K. Kiss), giedrius.lelkaitis@
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.kjaer@regionh.dk (A. Kjær),
).
Ltd. This is an open access article upurposes. Technically a neck dissection may be defined as the
surgical removal of potential or verified cervical nodal metastatic
disease including surrounding fibro-fatty tissue within anatomi-
cally defined compartments of the neck between the superficial
subplatysmal fascia and the deep cervical fascia. Since systematic
management of regional lymphatics by neck dissection was first
described by Criel in 1906, the procedure has developed from a
radical approach in direction of a selective approach with reduced
surgical invasiveness and morbidity by sparing non-lymphatic
structures, without compromising oncological safety [1,2]. The di-
vision of the neck compartment into levels by anatomical land-
marks, as described in the Robbins classification, serves the
important purposes, both to define the extent of a neck dissectionnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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reporting of findings in the resected neck specimens [3]. The
knowledge of reported patterns of metastatic spread to the neck
from different tumor subsites in the upper digestive tract has
allowed defining which levels should be included in the neck
dissection [4].
Lymph node yield (LNY), defined as the total number of detected
lymph nodes (LN) in a dissection specimen, is an established
prognostic factor in several solid malignancies like colorectal,
breast, bladder and esophageal cancer [5e8]. Equally, lymph node
ratio (LNR), defined as the number of metastasis divided by the
nodal yield, has been reported to be an independent prognosticator
for outcome, that may serve as a tool to stratify patients for adju-
vant therapy [9,10]. In head and neck cancer, accumulating evi-
dence supports the importance of both LNY and LNR as powerful
independent prognostic factors for outcome. However, their role in
the selection of patients for either radiation or chemo-radiation
remains unreconciled [11e13]. Also, as a metric for surgical treat-
ment quality, LNY has been suggested as a tool to reflect the
completeness or thoroughness of a neck dissection [14]. Currently,
no consensus has been established regarding minimal threshold
values of LNY or LNR in neck dissection [15]. In the newly updated
8th Edition AJCC/UICC staging manual a recommended minimal
LNY of 6 nodes in an elective ND, and 15 nodes in a therapeutic ND,
is stated, which is a very conservative guideline compared to re-
ported thresholds in the bulk of published literature [16]. Inher-
ently LNY, apart from the surgical procedure itself, also depends on
the postoperative histological work-up in the process of identifying
the lymph nodes [17].
Optical-guided surgery is a rapidly developing technology based
on intraoperative real-time imaging of injected or intrinsic fluo-
rescent molecules to aid surgical procedures. Both non-targeted
and targeted strategies have been investigated, and the number
of preclinical data is growing rapidly. Especially in oncological
surgery, the concept of intraoperative real-time targeted imaging of
tumor and metastatic disease to guide surgical resection holds a
great potential to impact future cancer treatment [18]. Several ap-
plications of optical imaging using non-targeted Idocyanine Green
(ICG) have been explored clinically, including optical-guided
sentinel node biopsy (SNB) for staging the regional nodal basin in
malignant melanoma, breast and cervical cancer [19e21]. Our
group and others have previously investigated a combined radio-
and optical-guided SNB technique using a bimodal tracer complex
with beneficial hydrodynamic properties by mixing radioactive
technetium-labeled Nanocoll and ICG [22,23]. In the current study
we expanded the concept of SNB to identify neck nodes directly
connected to the drainage from the primary tumor, by using a
monomodal ICG-colloid tracer complex and optical imaging both
intraoperatively during the neck dissection procedure, and for
ex vivo assessment of the resected neck specimen. To our best
knowledge, the possible influence of additional optical imaging on
LNY in head and neck cancer has not previously been reported.
The objective of this study was to examine the potential influ-
ence of optical imaging on LNY compared to standard white light
surgery in neck dissection in a randomized prospective study
design.
Materials and methods
The study was conducted as a single-institution randomized
clinical trial at the Department of Otolaryngology e Head & neck
Surgery at Rigshospitalet, Copenhagen University hospital, which is
a tertiary high-volume head and neck cancer referral center
covering Eastern Denmark with a population of approximately 2.8
million. Patients with primary oral squamous cell carcinoma (OSCC)and neck metastasis present at time of diagnosis (cT1-T4, Nþ)
scheduled for primary tumor resection and therapeutic ND was
included in the study. Staging was based on the 7th edition of the
TNM AJCC/UICC system. Exclusion criteria were cN0 status, prior
surgery or radiotherapy to the neck, severe kidney failure, preg-
nancy, known allergy to ICG or Iodine and untreated hyperthy-
roidism. Patients with cN0 status were excluded, because this
patient group routinely is managed by SNB for staging of the neck
as a standard procedure in our center and not elective ND. All pa-
tients were preoperatively evaluated by clinical examination, neck
ultrasound, MRI and CT if bone involvement was suspected. The
decision to perform unilateral or bilateral ND was made preoper-
atively in both study arms based on tumor location and laterality of
neck metastasis. The study was monitored by the GCP unit of
Copenhagen and conducted in accordance with the Helsinki
Declaration. The study was approved by the Regional Scientific
Ethical Committee, The DanishMedicines Agency and the European
Medicines Agency (EudraCT 2013-003578-28, www.
Clinicaltrialsregister.eu). Informed written consent was obtained
before enrolment in the study.
The design was a non-blinded two-arm randomized study. The
needed study sample in the control arm and the intervention arm
was estimated from a power calculation, based on an alfa-value of
5%, a power of 80%, an enrolment ratio of 1:1 and a minimal rele-
vant detected difference in LNY of 2/patient between the two
groups. The estimated sample size was 14 neck sides/group, and we
decided to include 18 neck sides in each group. The primary
endpoint was LNY in levels Ib-III. The randomization was per-
formed prior to trial initiation using a free-software random
number generator (www.random.org) and the generated
randomization key was stored by an external partner to be con-
sulted for inclusion and subsequent randomization of individual
consecutive patients.
Preparation of imaging agent
An ICG stock solution was prepared by adding 5ml of sterile
water to a vial of 25mg of dry compound ICG (Pulsion Medical,
Germany). Nanocoll (GE Healthcare, UK) was prepared by adding
2ml of isotone saline water to a vial containing 0.5mg of human
albumin colloid (GE Healthcare, UK). Then 0.2ml of the ICG solution
and 0.2ml of the Nanocoll was carefully mixed in a syringe and left
for 5min of incubation. The final mixture with a volume of 0.4ml,
containing 1mg of ICG (3.2mM) was prepared in a 1ml syringe
with a 25G needle for injection. Based on electron microscopy
imaging it has been estimated, that the molar ICG/nanocoll ratio in
the unconjuncgated ICG-Nanocoll tracer complex, where Nanocoll
is saturated with ICG, is 61:1 [24]. The molar ICG/nanocoll ratio of
the ICG-Nanocoll tracer complex used in this study was 1.800:1.
Therefore, in the injected tracer preparation, a substantial part of
ICG was unbound ICG, to allow rapid drainage to the entire tumor-
related neck lymphatics. Patients were injected the day before or
the day of surgery after application of local spray anesthesia in four
submucosal peritumoral deposits.
Imaging and perioperative procedures
The tumor ablation procedure was performed prior to the neck
procedure. In the oral cavity reconstruction was managed locally
with or without local flaps, no free flaps was used. Optical imaging
was performed with a Fluobeam 800 camera system (Fluoptics,
France), which is a clinically approved device with accompanying
software operated from a laptop. Real-time imaging was presented
for the surgical team on a monitor and the camera head was
brought to the surgical field in sterile draping for hand-held
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parabolic lights were turned away from the surgical field to avoid
imaging interference. The system works with laser excitation
(768 nm) and an autofocus function to allow movement-
independent focused video imaging. In all cases the same surgical
approach in the ND was applied through a single curved horizontal
neck incision, and as a minimum levels Ib-III was included in the
ND. Determined by extend and location of nodal metastasis, and by
preference of the individual surgeons, levels Ia, IV, Va or Vbwas also
included. Specimens were divided on the table into individual
levels. Mono-polar bovie knife was not used.
In the intervention group, optical navigation was first applied
before skin incision to access transcutaneous signals and then
intermittently during the ND. Finally, a systematic search was
conducted of each dissected level strictly defined by the anatomical
boundaries for optical signals left behind. It was recorded, if addi-
tional optical imaging of the neck following the completed ND
caused further dissection and resection of fibro-fatty tissue con-
taining LN. Further, on the back table in the OR each resected neck
level specimen was mounted on a cork plate and optical imaging
with the optical camera fixed on an in-house made surgical arm
was performed. All hot spots of fluorescence suspected to be LN
were marked with needles before being submitted for histopath-
ological processing.
In the pathology department, neck specimens from the control
group was managed according to a standard procedure, that
included macroscopic inspection and manual palpation of the
formalin-fixed tissues to identify and dissect individual LN. In the
intervention group tissues from all needle markings in the speci-
mens were secured for microscopy, before standard inspection and
palpation for lymph nodes was performed. All secured tissues from
neck specimens in both study arms were cut in 2mm thick slices,
paraffin embedded, routinely proceeded and 4 mm thick slides were
stained for Hematoxylin and Eosin. The histological evaluation wasTable 1
Patient cohort overview.
Case No. Group Age Sex T-site cTNM pTNM
2 Control 50 F Floor of mouth T2N1M0 T2N2bM
5 Control 65 M Lateral tongue T3N1M0 T3N2bM
7 Control 56 M Floor of mouth T2N2bM0 T2N2cM
9 Control 75 F Lower gum T4aN1MO T4N0M0
11 Control 39 F Buccal mucosa T2N2bM0 T2N2bM
14 Control 66 M Floor of mouth T2N1M0 T2N1M0
16 Control 66 M Floor of mouth T3N1M0 T3N2bM
18 Control 71 M Lateral tongue T2N1M0 T2N1M0
20 Control 78 M Lateral tongue T3N1MO T2N1M0
21 Control 63 M Lateral tongue T3N2cM0 T2N2cM
23 Control 52 M Inferior tungue T3N2bM0 T2N2bM
26 Control 57 F Floor of mouth T4aN2bM0 T4aN2b
28 Control 66 M Lateral tongue T2N1M0 T2N2bM
29 Control 61 F Retromolar region T1N1M0 T2N1M0
32 Control 79 F Buccal mucosa T1N1M0 T1N1M0
1 NIRF 55 M Lateral tongue T2N1M0 T2N2bM
3 NIRF 55 M Lateral tongue T3N1M0 T3N1M0
6 NIRF 58 M Floor of mouth T3N1M0 T3N2bM
8 NIRF 80 M Buccal mucosa T2N1M0 T2N2bM
10 NIRF 71 M Lower gum T1N1MO T1N2bM
12 NIRF 42 M Upper gum T4aN1M0 T4aN1M
13 NIRF 68 M Lateral tongue T3N1M0 T4aN2b
15 NIRF 70 M Floor of mouth T2N1M0 T2N1M0
17 NIRF 67 M Floor of mouth T1N1M0 T1N2bM
19 NIRF 55 M Lateral tongue T2N2bM0 T2N2bM
22 NIRF 63 M Lower gum T4aN1M0 T4N1M0
24 NIRF 67 M Lateral tongue T3N2cM0 T2N2cM
25 NIRF 75 F Lower gum T2N2bM0 T2N2bM
27 NIRF 82 F Buccal mucosa T1N1M0 T1N1M0
30 NIRF 56 M Floor of mouth T4aN2cM0 T4aN2c
31 NIRF 54 F Retromolar region T4aN1N0 T4aN1Mdone by a trained head and neck pathologist. Tumor deposits were
classified asmacrometastasis (ma, 2mm), micrometastasis (mi, <
2mm and 0.2mm) or isolated tumor cells (ICT, < 0.2mm) [25].
Data analysis
Data analysis was performed using SAS Enterprise software
Version 9.4 (SAS Institute A/S, USA). A value of p< 0.05 was
considered statistically significant, and two-sided testing was
applied in all calculations. The primary endpoint, difference in LNY,
was analyzed as a continuous viable by a Student T-test. For com-
parison of clinicopathological data between groups, Fisher's exact
test, Chi Square test, Student T-test or Wilcoxon test were used
when appropriate. Descriptive statistics are presented as mean,
median, range and percentages.
Results
A total of 31 patients were included, with 15 patients in the
control arm and 16 patients in the NIRF arm. Three patients in the
control group, and 2 patients in the NIRF had bilateral ND,
respectively. Therefore, in each group 18 neck-sides were available
for evaluation (Table 1). Comparison of demographics and clinico-
pathological variables between the two groups is presented in
Table 2. No statistically significant differences were detected be-
tween the two groups. The overall cohort had a male dominance
and themajority of the tumors were located on the tongue or in the
floor of the mouth.
Intraoperatively in the NIRF group, optical imaging during ND
allowed to detect individual LN embedded in fibro-fatty tissue with
a well-demarked and bright signal (Fig. 2). In some cases, also
lymphatic channels connected to individual LN could be presented
due to ICG imaging. Ex vivo, imaging of individual neck level
specimens on the back table showed a preserved and intenseND ND Laterality Met location by level Met number
0 Ia-III Unilateral 1b 5 ma
0 Ib-III Unilateral 2a þ3 5 ma þ 1 mi
0 Ia-III, V Bilateral 1b þ 1a contralateral 1 ma þ 1 mi
Ib-III Unilateral 1 b 1b
0 Ib-III Unilateral 1b 1 ma
Ia-IV Bilateral 1b 1 ma
0 Ia-IV Unilateral 1b þ 2b 2 ma
Ib-III Unilateral 2a 1 ma
Ia-III Unilateral 2a 1 ma
0 Ia-III Bilateral 1b, 2a, 3 contralateral 5 ma
0 Ia-IV Unilateral 1b, 2a 2 ma
M0 Ia-IV Unilateral 3 2ma
0 Ia-III Unilateral 2a 2 ma
Ib-III Unilateral 2a 1 ma
Ia-IV Unilateral 1b 1 ma
0 Ia-III Unilateral 1a þ 2a 2 ma
Ia-III Unilateral 2a 1 ma
0 Ia-III Unilateral 1b 3 ma
0 Ia-IV Unilateral 1b þ 2a 3 ma
0 Ia-III Unilateral 1b þ 3 2 ma
0 Ia-IV Unilateral 1b 1 ma
M0 Ib-III Unilateral 1b þ 2a 2 ma
Ia-III Bilateral 3 1 ma
0 Ia-III Unilateral 1b 2 ma
0 Ia-III Unilateral 2a þ3 12 ma
Ia-III Unilateral 2a 1 ma
0 Ia-IV Unilateral 3, 2a 2 ma
0 Ia-III Unilateral 1b, 2a 3 ma
Ia-III Unilateral 2a 1 mi
M0 Ia-III, V Bilateral 1b þ 1b and 3 contralateral 3 ma
0 Ib-III Unilateral 2a 1 ma
Table 2
Comparative statistics between study groups.
Variable Control group
N¼ 15
NIRF group
N¼ 16
p value
Agec (mean) 63 64 0.64
Sexa
Male 9 13 0.25
Female 6 3
Tobaccob
Pack years (mean) 36,9 34.2 0.65
Alcohola
Current 7 3 0.16
Former 1 4
Never 7 9
BMId (mean) 21.9 24.8 0.21
T-sitea
Buccal 2 2 0.06
Upper gum 0 1
Lower gum 1 3
Hard palate 0 0
Floor of mouth 5 4
Lateral tongue 5 5
Inferior tongue 1 0
Retromolar region 1 1
cTNM stageb
Stage 3 9 11 0.61
Stage 4 6 5
cT stagea
T1 2 4 0.61
T2 7 5
T3 5 3
T4 2 4
cN stagea
N1 10 12 0.62
N2a 0 0
N2b 4 2
N2c 1 2
pN stagea
N1 7 6 0.88
N2a 0 0
N2b 6 8
N2c 2 2
N-site up-stagingb
Yes 5 6 0.81
No 10 10
N site procedure timec (mean) 116min 90min 0.06
a Fisher's exact test.
b Chi Square test.
c Student T-test.
d Wilcoxon rank sum test.
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in individual hot spots (Fig. 3). In 13 out of 16 cases (81%), imaging
of the completed neck levels led to additional resection of tissue
guided by the optical signals detected. Eight of 16 patients (50%)
had the tracer injection the day before surgery (mean 14 h, range
11e19 h) with no apparent difference in intraoperative imaging
quality, compared to patients injected on the same day of surgery
(data not shown). Pre-incision transcutaneous imaging of the neck
detected localized signals in 3 of 16 cases (19%).
In one case, for exploratory purposes, the optical camera system
was transferred to the department of pathology the day after sur-
gery to perform imaging of a formalin fixed ND specimen. The in-
dividual optical signals marked with needles were found to be fully
preserved after tissue fixation (data not shown).
A total of 390 LN were detected in the control group and 468 LN
in the NIRF group after pathology workup of neck specimens. The
mean LNY from ND level Ib-III was 18 LN (CI 95% 15.0e21.8, range:
10e36 LN) in the control group and 24 LN (CI 95% 20.8e27.2, range:
12e33 LN) in the NIRF group, respectively. The difference in LNY
between the two groups was statistically significant (p¼ 0.016)
(Fig. 1). In the NIRF group, 335 out of 468 resected LN (71.6%) wereidentified ex vivo by the fluorescent signal and needle markings. In
addition 24 out of 359 needle markings (6.7%) were false positive,
as the optical signal did not represent LN on histology but only
connective tissues. All LN metastasis confirmed on histology were
in both groups located within level Ib-III and in the NIRF group all
LN with metastasis were also identified by NIRF imaging. No
adverse reactions related to the bimodal tracer agent occurred. No
difference in metastatic yield, expressed as either pN stage or
pathological N-site upstaging, between the two groups was
observed (Table 2).
Discussion
This study showed a significantly improved LNY in therapeutic
ND by additional use of an optical tracer compared to a control
group with standardized comparison of the extent of dissected
neck levels. By adapting the sentinel node concept, this technique
enabled real-time intraoperative imaging of tumor-related
lymphatic drainage to the neck basins. Not all LN in the neck
were stained with tracer, as demonstrated with the needle mark-
ings, which indicates, that the neck lymphatics is not a completely
interconnected meshwork of lymph nodes and lymphatic vessels.
This observation correlates with findings from SNB studies in oral
cavity cancer, where different drainage patterns in the neck from
individual tumor subsites have been observed [26]. The tracer was
designed to exhibit both retention in the first echelon nodes due to
non-covalent binding of ICG to Nanocoll, and simultaneously to
allow downstream drainage of excessive amount of non-bound ICG
to the entire neck basin of each individual tumor. Hence, optical
imaging of tumor-specific drainage may increase the chance of
resecting potential subclinical metastatic lymph node deposits
because of direct intraoperative guidance towards tumor-invaded
nodes, which is the major course of failure in the neck following
ND. The fundamental challenge in lymphadenectomy is not to
resect as many nodes as possible, but to resect the right nodes that
harbor clinically evident and subclinical metastatic disease to
achieve N-site radicality. The limited number of optical false-
positive findings was most likely due to transected lymphatic
vessels and spillage of tracer agent into adjacent non-lymphatic
tissues. Transcutaneous imaging of the lymphatic neck drainage
was not feasible in this study. We have previously reported similar
findings for ICG-based optical-guided SNB in the head and neck
region [22]. The penetration depth of NIR photons in biological
tissues is ½-1 cm, and the lymphatics below the platysma muscle
seems to be located too deep to achieve adequate optical pene-
tration for reliable imaging.
For comparison, only a limited number of papers concerning
optical imaging of ND have been published. Digonnet and colleges
demonstrated, in a series of 11 patients with HNSCC of different
sub-sites, the ability of intravenously injected ICG to distinguish
metastatic LN from negative nodes during ND based on a difference
in signal intensity [27]. Similar, in preclinical models, Ashitate et al.
investigated combined SNB and imaging of the entire nodal basin
by local and systemic injection respectively of two fluorophores
with different emission spectrums [28]. Both these studies used
systemic administration of fluorescent dyes looking for differences
in perfusion of lymphatics to image regional lymph node basins
that differs from the current study, where passive drainage from
the tumor site to the neck lymphatics was explored. To achieve
tracer drainage to the entire neck lymphatics, and not only a subset
of tumor-connected lymphatics, we propose several injection
points in the oral cavity guided by known drainage patterns from
different subsites deducted from SNB studies.
In contrast, optical-guided SNB using different tracer agents in
head and neck cancer have been investigated in several studies. Use
Fig. 1. LNY/neck side level 1b-3.
Fig. 2. NIRF imaging of neck lymphatics. Representative examples from six different patients of real-time intraoperative imaging of optical-guided ND with a Fluobeam camera
system. Gray scale optical imaging merged on black and white video imaging was presented for the surgical team on a monitor. Individual LNs are seen with a bright optical signal
sharply demarcated from the adjacent fibro-fatty tissue in the surgical field.
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administrated as separate injections has been studied in oral an
oropharyngeal cancer [29e32]. Two of these studies reported
suboptimal retention in the SN with inappropriate overflow of
tracer to down-stream neck lymphatics [29,31]. These findings
weremost likely caused by the known fast transit time of ICG in the
lymphatic system, and the moderate and transient retention of ICG
in the SN. Traditionally Blue Dye has been used for SNB to visualize
lymphatic drainage in OSCC and other malignancies, in a similar
way to the use of ICG. However, several studies have shown, that
methylene blue was outperformed by ICG for SNB due to superior
retention in the SN [33e35].
Optimal retention in the SN can be achieved by mixing ICG witha colloid, to form a non-convantly bound tracer complex with
favorable hydrodynamic properties. In addition, combined optical-
and radio-guided SNB is feasible which has been demonstrated in
OSCC and other malignancies in the head and neck region
[22,23,36].
In this study we combined the retention effect of a colloid and
the limited retention of unbound ICG to achive a tracer agent that
exhibited retention in first echelon nodes, that most likely will
contain clinical or subclinical metastasis, and simultaneous
drainage of unbound ICG to down-stream neck lymphatics. We
decided not to perform radioactive labeling of the tracer compound
in this study because the aim was not SNB staging but therapeutic
ND. Also, in OSCC the nodal template for SN distribution is well
Fig. 3. Ex vivo NIRF imaging of ND specimens. A and B: Examples of imaging of level 1 specimens from two different cases. Black and white (BW) imaging upper row, NIRF imaging
lower row. SMG¼ submandibular gland. C: Examples of NIRF imaging of level 3 specimens from two different cases. Needles were placed in individual NIRF signals (white single
arrow). Optical imaging allowed identification of interconnecting lymphatic vessels (red arrow).
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For comparison, in prostate cancer the metastatic distribution
pattern is more unpredictable and bimodal ICG-Technetium99m-
Nanocoll for SNB staging has proved valuable to detect SN
outside the expected draining nodal basins [37]. Hence, radio-
labeling would in theory have allowed to detect bilateral or
contralateral lymphatic drainage preoperatively on SPECT/CT to aid
surgical planning.
Many reports on LNY in ND differ in type of ND performed or
lack information about the extent of ND by levels, hence direct
comparison of yields and suggested cut-off values is difficult [11]. In
addition, most previous reports were based on LNY in elective ND
in cN0 cases. However, the mean LNY in therapeutic ND has been
reported to be higher compared to elective ND. For example, in a
retrospective study based on SEER data from 4618 OSCC patients,
Kuo and colleges found amedian LNY in cN0 and in cNþ cases of 20
LN and 25 LN, respectively. Same study established statistically
prognostic cut-off values for LNYof 16 LN in cN0 necks and 26 LN in
cN þ necks [38]. Interestingly, only the group, who had optical-
guided ND in this study, had a comparable median LNY of 26 LN.
As both LNY itself and LNR, that incorporates LNY, have been
strongly associated with survival outcome in head and neck cancer,
it is plausible that the proposed technique of optical imaging in the
current study will have impact of patient outcome as well. Further
high-powered clinical studies of optical-guided ND and a possible
impact on survival outcome are warranted.
The positive effect of optical-assisted ND on LNY is most likely acombination of increased LN detection both intraoperatively as well
as during histological processing. However, we did not specifically
in this study investigate the individual effect of optical imaging on
surgery and histological workup, respectively. In 81% of cases
additional dissection was undertaken due to optical imaging, most
often in level 1 below the edge of the mandible and in level 3
posterior to the internal jugular vein. In the initial assessment of
the neck level specimens, needle markings identified small LN,
which very likely would not have been detected by standard
techniquewith inspection and palpation. As optical guidance in this
study resulted in a higher LNY compared to a control group, most
likely due to both the adequacy of the surgery, and the thorough-
ness of the pathological workup, this technique may be of special
importance for head and neck surgeons and pathologists during
training of these procedures to improve learning curves and as a
tool for quality metrics [39]. Because optical guidance caused
additional dissectionwithin the anatomically defined neck levels in
the majority of the patients, there is a possible risk that this
approach could increase the morbidity, in particular damage of the
marginal branch of the facial nerve and the spinal accessory nerve.
Morbidity from ND in the two study arms was not an endpoint in
this study, but along with possible impact on survival outcome,
change in morbidity should be investigated in clinical studies
ahead.
The principle of optical-guided ND was feasible, and it did not
prolong the neck procedure compared to the control group
(Table 2). However, the need to intermittently turn away surgical
A. Christensen et al. / European Journal of Surgical Oncology 45 (2019) 2151e2158 2157lights to perform optical imaging was inconvenient for the sur-
geons, and interference with lights from head lights was a chal-
lenge. In a future setup, a camera system with video color and
merging of the optical signal unaffected by ambient light to opti-
mize the intraoperative integration of optical imaging and surgical
workflow is requested.
The sample size of the study was a limitation. Further, the re-
sults stem from a single-institution experience and individual
technique among surgeons may have introduced elements of bias.
Also, because a possible effect of a device applied intraoperatively
was explored, blinding each surgeon to the type of ND in the two
study arms was not technically possible. This study designmay be a
possible source for bias. The study did not include survival outcome
and therefore did not investigate a possible impact of optical-
guided ND on survival.
Conclusions
The results in this study revealed in a clinical setting a signifi-
cantly higher LNY in OSCC patients with clinically node-positive
necks achieved by optical-assisted ND compared to a control
group in a randomized study design. Preoperative peritumoral in-
jection of an ICG-based tracer formulation permitted real-time
imaging of tumor-related drainage to the neck lymphatics to
identify individual LN intraoperatively as well as postoperatively in
dissected specimens. Further studies should be directed at inves-
tigating optical-guided lymphadenectomy in other types of ma-
lignancies with regional metastatic spread and the possible impact
of survival outcome due increased LNY.
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